Efficacy of a Genetically Engineered Candida albicans tet-NRG1 Strain as an Experimental Live Attenuated Vaccine against Hematogenously Disseminated Candidiasis

We report on the efficacy of the genetically engineered Candida albicans tet-NRG1 strain as an experimental live, attenuated vaccine against disseminated candidiasis in both immunocompetent and immunodeficient mice mostly dependent on T-cell immunity. This experimental vaccination model may represen...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Saville, Stephen P., Lazzell, Anna L., Chaturvedi, Ashok K., Monteagudo, Carlos, Lopez-Ribot, Jose L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 2009
Aiheet:
Vaccine Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2650868/
https://ncbi.nlm.nih.gov/pubmed/19144791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00480-08
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia